Monoclonal Antibodies
Monoclonal Antibodies Companies (30)
Monoclonal Antibodies News
-
.png)
News Eisai Alzheimer’s drug authorised in UK but still faces obstacles
In partnership with BioArctic AB, pharmaceutical company Eisai has been granted Marketing Authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) for its Alzheimer’s disease drug product Leqembi.
-
.png)
News Eli Lilly’s Alzheimer’s drug receives approval from US FDA
After facing several hurdles on its path to approval last year, Eli Lilly’s donanemab treatment for early Alzheimer’s, brand name Kisunla, received US FDA approval this past week. It is the second therapy for slowing the progression of Alzh... -
.png)
News New Aurigene biologics facility opens in Hyderabad, India
Aurigene Pharmaceutical Services Ltd. have opened a biologics facility in Hyderabad, India in a biocluster known as Genome Valley.
-
News Alzheimer's drug donanemab deemed effective in landmark clinical trial
Results from the TRAILBLAZER-ALZ 2 Randomised Clinical Trial into the use of donanemab to treat early symptoms of Alzheimer’s disease have been analysed.
.jpg)
Monoclonal Antibodies Products (56)
-
Product Trastuzumab Injection 440 mg
Description: Sterile injectable formulation containing trastuzumab, a monoclonal antibody used in the treatment of HER2-positive cancers, particularly breast and gastric cancers. Administered intravenously or subcutaneously under medical supervision.
Therapeu...
-
Product Bioanalytical Services
Accurate and reliable measurement of drug concentrations and biomarkers in biological matrices is fundamental to drug development success. ResolveMass Laboratories offers GLP-compliant bioanalytical method development and validation for a broad range of analytes — spanning small molecules, large molecules,...
-
Product Biologic drug substance CDMO services
From early development, including mammalian cell line development, cell culture development, and process development, through to pre-clinical production and commercial supply, Patheon by Thermo Fisher Scientific provides CDMO services for protein-based biologic therapeutics. Patheon offers biotech and ...
-
Product EZ-fill® Large Volume Cartridges
Designed for the delivery of high-volume, high-viscosity biologics, EZ-fill® Large Volume Cartridges support treatments for several conditions such as autoimmune, oncology, rare diseases and Parkinson’s.
With 10+ years of expertise in large-volume containers, we are a trusted partner for...
-
Product MabionCD20
This is our most advanced in-house project. A MabThera/Rituxan (rituximab) biosimilar drug, whose efficacy and safety were clinically confirmed. It is the first such advanced drug developed in Poland. We are currently at the final stage of works aimed at marketing the drug in Europe and the United States.
-
Product Tocilizumab Injection
English Name: Tocilizumab Injection
Dosage Form: Solution for injection
Specification(Dosage): 80mg/4mL/vial
Indication: Indicated for rheumatoid arthritis, systemic juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome.
qq...
-
Product Microbial Fermentation Contract Manufacturing
Advancing your microbial therapies with expertise, scale and quality
Microbial therapies face unique challenges, from complex fermentation scale-up to safeguarding long-term supply. With microbial fermentation capacity across the global Pfizer network, we help bring the scale, resilience ...
-
Product Biopharmaceutical Development Support Services
Fundamental to your biopharmaceutical chemistry, manufacturing and controls (CMC) development, you will need detailed analytical characterisation data to satisfy regulatory requirements. Our experts strategically deploy orthogonal protein analysis approaches that address key molecular and biological charac...
-
Product Biotechnology Contract Development and Manufacturing
Bayer is offering CDMO Services for Biotechnological Products! The Future is Now. Bayer is your reliable Partner for your Innovation.
You are looking for a partner to develop and commercialize you biotechnological asset?
Whether it is a Protein, a Cell Therapy or Gene Therapy Product...
-
Product Stability Studies (Non-GMP and GMP)
As part of formulation development projects, supply of preclinical, clinical or commercial material, or as a standalone service package, Coriolis performs stability studies in accordance with ICH guidelines using suitable climate chambers at controlled temperatures and relative humidity (RH). In addition t...
-
Product Selexis® SUREmAb™
SUREmAb™, built on the Selexis® SUREtechnology Platform™, is KBI Biopharma’s dedicated solution for the rapid development of monoclonal antibodies (mAbs). Designed to streamline timelines without compromising quality, SUREmAb enables biotech innovators to move from DNA to GMP drug substance in as little as...
-
Product Biologics
End-to-end development and manufacturing capabilities across different therapeutic modalities and the entire product lifecycle
Cutting-edge technology platforms for high yielding cell lines (both mammalian and microbial) and high concentration formulations
Integrated and flexible drug sub...
-
Product Biologics - mAbs, therapeutic proteins and ADC development
Eurofins CDMO Alphora Inc. provides integrated solutions for small molecules, drug product, biologics and phytocannabinoids. Specializing in complex and niche small molecule drug substance and drug product services, including high potent capabilities, we provide support from preclinical to commercial devel...
-
Product HANBEITAI (Bevacizumab Injection)
HANBEITAI (generic name: bevacizumab), the fourth product independently developed by Henlius, received marketing approval from the National Medical Products Administration (NMPA) in November 2021, and its commercialization in Chinese mainland is handled by the company’s in-house team. As of now, HANBEI...
-
Product UV Light Blocking Tyvek Equipment Covers
UV Light Blocking Tyvek Equipment Covers are designed to keep cleaned pharmaceutical equipment and supplies clean and protected from external sources of contamination while also providing in-process protection to light sensitive biotech products.
-
Product Biologics Contract Manufacturing
Chime Biologics is a leading global CDMO, focused on ensuring our customers' success in delivering innovative biologic medicines to patients across the world. Chime Biologics can support customers end to end, from pre-clinical support and cell line development through to clinical and commercial manufacturi...
-
Product Ramucirumab
Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.
High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.
High degree o...
-
Product SYN023 (Zamerovimab and Mazorelvimab Injection)
Zamerovimab and Mazorelvimab Injection (SYN023) is the World’s First Humanized mAb Cocktail against Rabies. It has approved in China since 2024.
-
Product Monoclonal Antibodies GMP
GMP manufacturing of Monoclonal Antibodies for early-phase through all clinical stages
Also serving the Diagnostic industry with high quality antibodies
Exporting antibodies worldwide, including the US
-
Product Biosimilar Development Services
The development of biosimilar products demands an exceptional level of analytical precision and regulatory sophistication. ResolveMass Laboratories provides end-to-end analytical and bioanalytical support across all stages of the biosimilar development continuum — from early feasibility and fingerprinting ...
Upcoming Events
-
CPHI & PMEC China 2026
Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026 -
CPHI South East Asia 2026
QSNCC, Bangkok, Thailand
08 Jul 2026 - 10 Jul 2026 -
CPHI Korea 2026
COEX, Seoul, Korea
25 Aug 2026 - 27 Aug 2026
%20(1).png)
%20(1).png)
.png)
%20(1).png)
.png)
%20(1).png)
.png)
.png)
